Patent · US Active

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

US10106553B2 · kind B2 · utility

0Cited by

3References

19Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Sanath K. Meegalla · Boothwyn, US
Mark R. Player · Phoenixville, US
Hui Huang · Blue Bell, US
Michael Winters · Morgantown, US

Key dates

Filing date	Apr 11, 2017
Grant date	Oct 23, 2018
Priority date	—
Expiry date	Apr 11, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: wherein U1, U2, U3, R1, R2, Z, and W are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.